Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 16, 2009British Journal of Dermatology

Bexarotene therapy for mycosis fungoides and Sézary syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

RARachel AbbottCardiff and Vale University Health BoardSWSean WhittakerGuy's HospitalSMSteven Morris

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abbott et al. (2009) studied this question.

synapsesocial.com/papers/69d7c518f39344339dd181b8https://doi.org/10.1111/j.1365-2133.2009.09037.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The optimal use of bexarotene in cutaneous T-cell lymphoma2007 · 175 citations
  2. 2Incidence of Cutaneous T-Cell Lymphoma in the United States, 1973-20022007 · 529 citations
  3. 3Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids1994 · 375 citations